We examined correlates of late and delayed initiation of antiretroviral therapy (ART) in British Columbia, Canada. From December 2013 to December 2015 we recruited treatment-naïve people living with HIV who initiated ART within the previous year. 'Late initiation' was defined as CD4 cell count ≤500 cells/µL at ART initiation and 'delayed initiation' as ≥1 year between HIV diagnosis and initiation. Multivariable logistic regression assessed independent correlates of late and delayed initiation. Of 87 participants, 44 (51%) initiated late and 22 (26%) delayed initiation. Delayed initiation was positively associated with older age (adjusted odds ratio [AOR]: 1.06 per year, 95% confidence interval [95% CI]: 1.01-1.12) and inversely associated with wanting to start ART at diagnosis (AOR: 0.06, 95% CI: 0.02-0.21). Variables associated with late initiation were older age (AOR: 1.09 per year, 95% CI: 1.03-1.15) and medical reason(s) for initiation (AOR: 5.00, 95% CI: 1.41-17.86). Late initiation was less likely among those with greater perceived ART efficacy (AOR 0.94, 95% CI: 0.90-0.98) and history of incarceration (AOR: 0.12, 95% CI: 0.03-0.56). Disparities in timing of initiation were observed for age, perceived ART efficacy, and history of incarceration. Enhanced health services that address these factors may facilitate earlier treatment initiation.
Background
Since the advent of combination antiretroviral therapy (ART), health outcomes of people living with HIV (PLHIV) have improved greatly (Lima, Eyawo, et al., 2015) . ART has led to reductions in morbidity and mortality Lima, Reuter, et al., 2015) and decreased HIV transmission (Cohen et al., 2011) . The benefits of immediate ART initiation have been demonstrated by the TEMPRANO (T.A.S. Group, 2015) and INSIGHT START (Insight Start Study Group et al., 2015) studies. Further, modern regimens have fewer adverse effects (Margolis, Heverling, Pham, & Stolbach, 2014) and decreased pill burden and dosing frequency (Hernandez Arroyo et al., 2016) . Globally consensus has been reached; since 2015 guidelines uniformly recommend immediate initiation of ART regardless of CD4 cell count (Lundgren, Gatell, Rockstroh, & Furrer, 2015; Thompson et al., 2012; WHO, 2015) . Despite known benefits (Boyd, 2009; Solomon & Sax, 2015) , barriers to timely initiation persist (Cescon et al., 2015) .
We examined factors associated with delayed ART initiation in British Columbia (BC), Canada. This study adds a unique perspective to the literature by including only individuals who recently initiated ART. Additionally, this study took place in a setting where ART is publicly funded and universally available, and implementation and expansion of the Seek and Treat to Optimize Prevention (STOP) HIV/AIDS program has promoted timely linkage of individuals to HIV treatment (BC Centre for Excellence in HIV/AIDS (BCCfE), April 4, 2013). Nonetheless, 20-30% of PLHIV in BC initiated ART with CD4 cell counts ≤200 cells/µL quarterly and only 39% began ART with a CD4 cell count >500 cells/µL in 2015 (BCCfE, 2016 
Outcome variables
Late ART initiation is defined as CD4 cell count ≤500 cells/µL based on therapeutic guidelines for ART initiation in BC that recommend initiation at any CD4 cell count, and ≤500 cells/µL for long-term non-progressors (BCCfE's Committee for Drug Evaluation and Therapy, 2013). Late initiation is often defined by CD4 cell count, a clinical variable that indicates HIV disease progression, and is readily available for studies using clinical or administrative data. CD4 cell count at initiation was obtained from the most recent test result on or before the person's first ART prescription date.
Delayed initiation provided an alternate measure of timely ART initiation based on self-reported HIV diagnosis date, and is defined as ≥1 year between HIV diagnosis date and ART initiation. There is no standard definition of delayed initiation in the literature; this definition was chosen to ensure a sufficient time period to identify those who opted to delay treatment.
Explanatory variables
Key explanatory variables, established by previous research to impact timing of initiation (Cescon et al., 2015; Joseph et al., 2016; Lourenco et al., 2015; Palmer et al., 2014) , included: sex at birth, age, ethnicity, HCV seropositivity, history of IDU, history of homelessness, and income. Additional variables included in this analysis were: physician advice regarding ART initiation, medical reasons for initiating ART, concerns about ART, and participant scores on the Antiretroviral Medication Attitude Scale (AMAS) (Viswanathan, Aanderson, & Thomas, 2005) , the HIV Treatment Adherence SelfEfficacy Scale (HIV-ASES) (Johnson et al., 2007) , and the Continuity of Care Scale (Uijen et al., 2012) .
Statistical analysis
Univariable and multivariable logistic regression identified independent predictors of late and delayed ART initiation. Significant variables in univariable analysis (p-value < 0.05) were considered in the final multivariable model. In instances of collinear covariates, the variable with the higher effect size was used. The Akaike information criterion method determined the final model selection.
Results
Of 87 participants, 15 (17%) were female and 56% were from Vancouver Coastal Health Authority. The median age was 39 years (Q1-Q3: 29-46 years), 28% had a history of IDU, 20% were HCV-seropositive and 56% identified as men who have sex with men.
The median CD4 cell count at ART initiation was 510 (Q1-Q3: 280-660) cells/µL and 43 (49%) participants initiated late, with CD4 cell count ≤500 cells/µL, and 22 (26%) delayed initiation. Median time between HIV diagnosis and ART initiation was three months (Q1-Q3: 1-14 months). Table 1 compares participants to the 615 eligible nonrespondents. Median CD4 cell count was significantly higher among participants, while median age was significantly lower among study participants. Table 1 presents factors associated with late initiation among all eligible individuals. In multivariable logistic regression, factors positively associated with late initiation were: older age (AOR: 1.03 per year, 95% CI: 1.02-1.05 per year) and residence in the Island, Interior or Northern Health Authorities compared to Vancouver Costal Health Authority (AOR: 2.19, 95% CI: 1.42-3.37). Table 2 depicts participant characteristics dichotomized by CD4 cell count at ART initiation and results of univariable and multivariable analysis of factors associated with late initiation. In multivariable analysis, individuals of older age (AOR: 1.09, 95% CI: 1.03-1.15) and those who reported initiating ART due to medical reasons (AOR: 5.00, 95% CI: 1.14-17.86) were more likely to initiate ART late. History of incarceration (AOR: 0.12. 95% CI: 0.03-0.56) and higher HIV-ASES scores (AOR: 0.94, 95% CI: 0.90-0.98) decreased the likelihood of late initiation. Table 3 shows factors associated with delayed ART initiation. In multivariable analysis, older age was associated with delayed initiation (AOR: 1.06, 95% CI: 1.01-1.12), while those reporting wanting to start ART when diagnosed were less likely to delay initiation (AOR: 0.06, 95% CI 0.02-0.21).
Discussion
Consistent with prior results from BC, older age was associated with late and delayed ART initiation Palmer et al., 2014) . Notably, other research has found younger age to be associated with attrition in HIV care over time (Lourenco et al., 2014) , suggesting a missed opportunity to retain younger people. History of incarceration was negatively associated with delayed initiation. This is contrary to existing literature, which finds that incarceration makes timely ART initiation and adherence more difficult (Joseph et al., 2016; Milloy et al., 2011) . Extensive support programs for PLHIV experiencing incarceration in BC may explain these results (British Columbia Ministry of Justice, 2002; Correctional Service Canada, 2015) .
Participants with higher HIV-ASES scores or who reported wanting to start ART upon diagnosis were less likely to initiate late or delay initiation, respectively. Moreover, our finding that participants' selection of "medical reasons" for initiating ART contributed to late initiation suggests that some individuals are waiting until their health is compromised to start treatment. This is supported by the literature that indicates better health or lack of physical HIV symptoms is associated with delayed linkage to care (Hanna et al., 2013; Takah et al., 2016) , delayed diagnosis (Lee et al., 2010; Ndiaye et al., 2011) and treatment breaks (Begley, McLaws, Ross, & Gold, 2008; Newman et al., 2015) . Counseling on the benefits and costs of ART, including peer support programs or peer-developed information resources, may help address individual-level barriers to initiating and remaining on ART.
Based on prior studies in BC, variables we expected to predict late initiation included the history of IDU, HCV seropositivity, and lower income (Joseph et al., 2016; Lourenco et al., 2015; Palmer et al., 2014) . Our findings may reflect changing characteristics of new initiators in BC, or may be due to limited sample size and a high percentage of participants with a history of IDU and HCV seropositivity, which left little room to examine variability. Potential lack of generalizability due to significant clinical differences (i.e. CD4 cell counts at ART initiation) between participants and non-participants is another important limitation. Furthermore, this analysis does not include health providers' experiences of prescribing ART. Previous research has found that the lack of physician familiarity with the patient and patient depression were reasons for waiting to prescribe ART (Fehr et al., 2016) . Finally, our study may not have captured longer-term non-initiators of ART since individuals who delayed initiation for longer than the study period were unable to participate.
In conclusion, our results show that late ART initiation is less likely among individuals with a history of incarceration or higher HIV-ASES score, and more likely among older individuals or those who initiate ART due to medical reasons. Older age also predicted delayed ART initiation, and wanting to start ART when diagnosed with HIV reduced the likelihood of delay. While trends in BC show that fewer people are waiting after diagnosis to initiate ART, efforts are warranted to increase the number of people initiating ART early, for individual and population health benefits.
